Pharmaceutical form
1 tablet contains 0.1 g of thiotriazoline, equivalent to 100% substance;
excipients: microcrystalline cellulose, low molecular weight polyvinyl pyrrolidone (medical
grade), powdered sugar, potato starch, calcium stearate.
Chronic hepatites of various etiology, liver cirrhosis.
Ischemic heart disease: acute macro- and microfocal myocardial infarction, angina of effort,
angina at rest, postinfarction cardiosclerosis, heart rhythm disorders.
Hypersensitivity to the components of the drug; renal failure, children under 5 years of age;
pregnancy and lactation
Dosage and administration
For hepatic diseases, adults are usually prescribed 1 – 2 tablets 3 - 4 times daily for 20 - 30 days.
For angina of effort and angina at rest, myocardial infarction, postinfarction cardiosclerosis - 1 –
2 tablets 3 - 4 times daily for 20 - 30 days.
For heart rhythm disorders - 1 - 2 tablets orally or sublingually 3 times daily.
Children are prescribed 10-20 mg of Thiotriazolin per kilogram of the bodyweight daily in 3
divided doses.
The duration of therapy should be determined by a physician on an individual basis depending
on the severity and clinical presentation of the disease.
Side effects
When used in therapeutic doses, adverse reactions have not been reported.